High levels of pipeline activity are being observed in Coronary Artery Disease (Ischemic Heart Disease) treatment during 2019. Clinical development activities are being undertaken by more than 35 companies including advanceCor GmbH, AgeX Therapeutics Inc, AngioSoma Inc, APT Therapeutics Inc, Ascendia Pharmaceuticals LLC and others.
A Significant contribution to the Coronary Artery Disease (Ischemic Heart Disease) pipeline is being observed from emerging companies opting for new approaches to clinical development strategy. The early stage and late-stage Coronary Artery Disease (Ischemic Heart Disease) pipeline included 37 compounds, driven by increasing number of targeted therapies. Progress is being made in accelerating compounds into advanced stages. However, fluctuating trends are being observed in average duration across three phases.
Increased understanding of underlying causes of Coronary Artery Disease (Ischemic Heart Disease) condition and increased access to investments is encouraging growth of Coronary Artery Disease (Ischemic Heart Disease) drug pipeline. However, despite high levels of pipeline activity, increasing clinical trial costs and decreasing drug approval rates is requiring companies to focus more on understanding clinical development pipeline compounds.
The research study is structured to provide clear and actionable insights into Coronary Artery Disease (Ischemic Heart Disease) drug pipeline for companies to optimize spending levels by understanding competition, their pipeline products and prospect of further advances over the next few years.
The report addresses the discovery, research and pre-clinical stage active Coronary Artery Disease (Ischemic Heart Disease) therapeutic candidates. Further, drugs in clinical stage including phase 1, phase 2, phase 3 and pre-registration phases are also analyzed.
The current report examines the current Coronary Artery Disease (Ischemic Heart Disease) pipeline along with current development status, regulatory progress, mechanism of action, route of administration, collaborating companies, sponsors, molecule type, and research/discovery details.
In addition to drug overview, recent developments, the report also provides mechanism of action, Pre-clinical trial details and Clinical trial details for each of the drug candidates of Coronary Artery Disease (Ischemic Heart Disease). Further, orphan drug status, fast track designation, grants awarded and other special status for Coronary Artery Disease (Ischemic Heart Disease) pipeline compounds are also included.
This study was produced independently by VPAResearch from our proprietary databases, primarily to assist users to develop in-depth understanding of 2019 Coronary Artery Disease (Ischemic Heart Disease) pipeline and formulate effective research and development strategies.
Our integrated data reports are built through robust research methodology to ensure our users can build on the insights and data accuracy for their expansion plans. Both primary and secondary research methods are used with stringent quality checks at each stage to evaluate trends, analysis and forecasts.
Companies involved in the Pipeline- - Company overview
- Coronary Artery Disease (Ischemic Heart Disease) therapeutic treatment activities
Details for each Coronary Artery Disease (Ischemic Heart Disease) drug candidate- - Snapshot
- Drug Name
- Alternative Names
- Molecule Type
- Orphan Drug Status
- Drug Overview
- Mechanism of Action
- Current Status
- Trial Details
Other details - Pre-clinical trials for each drug candidate
- Clinical trials for each drug candidate
Recent Coronary Artery Disease (Ischemic Heart Disease) therapeutic candidates, clinical trials, investments, grants, partnerships, licenses, awards and other news
Our reports have been used by over 10K customers, including:
175 pages •
By The Business Research Company
• May 2021
Major players in the wearable injectors market are Amgen, Becton, Dickinson and Co., Enable Injections, Insulet Corporation, Ypsomed, Medtronic, Tandem Diabetes Care, Valeritas, West Pharmaceutical Services,and Sensile Medical AG. The global wearable injectors market is expected to grow from $5.145 billion in 2020 to $5.709 billion...
280 pages •
By Prescient & Strategic Intelligence Private Limited
• Mar 2021
Precision Medicine Market Research Report: By Type (Therapeutics, Diagnostics, Personalized Medical Care) - Global Industry Analysis and Growth Forecast to 2030
In July 2019, U.S. president Donald Trump decided to bring down the prices of drugs in the country to make them equal or similar to the international rates....
KEY FINDINGS The Europe oxygenators market is projected to develop with a CAGR of 5.27% over the forecast period of 2021 to 2028. Chief factors such as the surging healthcare expenditure, the increasing need for medical devices, the growing public and private investment in research and development, and the prevalence of...
KEY FINDINGS The global biosurgery market is forecasted to record a CAGR of 6.32% during the projected period of 2021 to 2028. The market growth is attributed to the rising geriatric population, the incidence of musculoskeletal disorders, technological advancements, and the increasing research and development endeavors. MARKET...
The pen needles market is expected to reach USD 2.2 Billion by 2026 from an estimated USD 1.3 Billion in 2021, at a CAGR of 11.2%. Growth in the market is largely driven by the growing prevalence of chronic diseases and the favorable reimbursement scenario in selected countries. On the other hand, the preference for alternative modes of drug...
175 pages •
By The Business Research Company
• Jul 2021
Major players in the live cell imaging market are Leica Microsystems, Olympus Corporation, Sigma-Aldrich Corporation, PerkinElmer Inc., GE Healthcare, Carl Zeiss Meditec AG, Becton Dickinson and Company, Molecular Devices LLC, Bruker Corporation, Sartorius AG, Oxford Instruments, BioTek Instruments, Etaluma Inc, and CytoSMART Technologies. The...
The global hyperspectral imaging systems market exhibited strong growth during 2015-2020. A hyperspectral imaging system can be defined as a technique used to analyze a wide spectrum of light through a spectrometer. The device uses reflected, transferred or emitted light from the object to generate its spectral-based...
The global breakfast food market exhibited moderate growth during 2015-2020. Breakfast food refers to various products that are consumed as the first meal of the day. Some of the most common types of breakfast foods include cereals, bread, eggs, porridge, waffles, pancakes, snack bars, bacon and sausages. They are majorly...
120 pages •
By Infiniti Research Limited
• Jun 2021
Global Biochip Market 2021-2025 The analyst has been monitoring the biochip market and it is poised to grow by $ 25.52 bn during 2021-2025, progressing at a CAGR of almost 23% during the forecast period. Our report on biochip market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges,...
Point Of Care Testing
Chronic Disease Prevalence
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.